-
公开(公告)号:US20200147151A1
公开(公告)日:2020-05-14
申请号:US16481187
申请日:2018-01-30
Inventor: Herbert L. DUPONT , Zhi-Dong JIANG
IPC: A61K35/742 , A61K47/26
Abstract: The present disclosure provides human fecal microbiota compositions, including fresh, frozen, and lyophilized compositions, for the treatment of disorders associated with dysfunctional microbiota, such as recurrent Clostridium difficile infection. In particular, the fecal microbiota composition comprises a cryoprotectant sugar, such as mannitol.